Prognostic Factors for Node-Negative Advanced Gastric Cancer after Curative Gastrectomy.
10.5230/jgc.2016.16.3.161
- Author:
Eun Woo LEE
1
;
Woo Yong LEE
;
Ho Seok KOO
Author Information
1. Department of Surgery, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
- Publication Type:Original Article
- Keywords:
Lymph nodes;
Prognosis;
Stomach neoplasms
- MeSH:
Follow-Up Studies;
Gastrectomy*;
Humans;
Korea;
Logistic Models;
Lymph Nodes;
Neoplasm Metastasis;
Prognosis;
Recurrence;
Retrospective Studies;
Seoul;
Stomach Neoplasms*
- From:Journal of Gastric Cancer
2016;16(3):161-166
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Lymph node (LN) metastasis is the best prognostic indicator in non-distant metastatic advanced gastric cancer. This study aimed to assess the prognostic value of various clinicopathologic factors in node-negative advanced gastric cancer. MATERIALS AND METHODS: We retrospectively analyzed the clinical records of 254 patients with primary node-negative stage T2~4 gastric cancer. These patients were selected from a pool of 1,890 patients who underwent radical resection at Memorial Jin-Pok Kim Korea Gastric Cancer Center, Inje University Seoul Paik Hospital between 1998 and 2008. RESULTS: Of the 254 patients, 128 patients (50.4%), 88 patients (34.6%), 37 patients (14.6%), and 1 patient (0.4%) had T2, T3, T4a, and T4b tumors, respectively. In a univariate analysis, operation type, T-stage, venous invasion, tumor size, and less than 15 LNs significantly correlated with tumor recurrence and cumulative overall survival. In a multivariate logistic regression analysis, tumor size, venous invasion, and less than 15 LNs significantly and independently correlated with recurrence. In a multivariate Cox proportional hazards analysis, tumor size (hazard ratio [HR]: 2.926; 95% confidence interval [CI]: 1.173~7.300; P=0.021), venous invasion (HR: 3.985; 95% CI: 1.401~11.338; P=0.010), and less than 15 LNs (HR: 0.092; 95% CI: 0.029~0.290; P<0.001) significantly correlated with overall survival. CONCLUSIONS: Node-negative gastric cancers recurred in 8.3% of the patients in our study. Tumor size, venous invasion, and less than 15 LNs reliably predicted recurrence as well as survival. Aggressive postoperative treatments and timely follow-ups should be considered in cases with these characteristics.
